KATHRYN SHELTON: Open Payments
NPI 1528452679 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,431 in 113 payments from 33 companies in 2025. Trend: 2023 $3,422 · 2024 $2,107 · 2025 $2,431
Food & beverage: $2,431
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $292 |
| AstraZeneca Pharmaceuticals LP | 9 | $240 |
| Janssen Biotech, Inc. | 8 | $214 |
| Celgene Corporation | 13 | $190 |
| Merck Sharp & Dohme LLC | 7 | $168 |
| PFIZER INC. | 8 | $166 |
| ABBVIE INC. | 8 | $160 |
| Incyte Corporation | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
Products named: REBLOZYL, KEYTRUDA, XTANDI, Fabhalta, TAGRISSO, EPKINLY, ERLEADA, NINLARO.
Industry payments across TN — which companies pay providers there.
